TELO READ THE FULL TELO RESEARCH REPORT Telomir Pharmaceuticals (NASDAQ:TELO) is a preclinical stage biopharmaceutical company developing a product designed to lengthen the DNA’s protective telomere ...

"I am pleased to be joining Terns as we advance our lead oncology and obesity programs towards important clinical readouts ...

International Stroke Conference of the American Heart Association/American Stroke Association was held from Feb. 5 to 7 in ...

WSU researchers have created HuT mice with human-like short telomeres, allowing for groundbreaking studies on aging, cancer, ...

Good morning, Oklahoma! Here's what you need to know today: ☀ Temperature check: Partly sunny and cold in Oklahoma City with a high of 45 degrees, low of 15. An arctic blast is expected to bring ...

Researchers at The University of Texas MD Anderson Cancer Center have identified a potential breakthrough in the fight ...

Total net revenues for the second quarter of fiscal 2025 increased 2% to $15.5 million, compared with $15.2 million in the ...

a clinical-stage biotechnology company focused on treating rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) ...

Researchers from the Tata Memorial Centre (TMC), Mumbai, and the National Institute of Biomedical Genomics (NIBMG) in West Bengal on Wednesday claimed to have found key genomic factors that contribute ...

Researchers from TMC and NIBMG have uncovered key genomic factors contributing to hormone treatment resistance in breast cancer. The study identifies mutations in three genes, DNA repair deficiencies, ...

Researchers are delving deeper into the role of leukocyte telomere length as it relates to stroke, dementia, and depression ...